Understanding the challenges and ethical aspects of compassionate use of drugs in emergency situations Goyal PK, Mathur R, Medhi B - Indian J Pharmacol
A case for compassionate use: When unapproved drugs are the only hope
I'm Willing To Try Anything': Compassionate Use Access To Experimental Drugs And The Misguided Mission Of Right-To-Try Laws | Health Affairs
Compassionate use of orphan drugs | Orphanet Journal of Rare Diseases | Full Text
Compassionate Use and other Managed Access Concepts - GMP Journal
Regulatory Explainer: FDA's Expanded Access (Compassionate Use) Program | RAPS
Ordinance on Medicinal Products for Compassionate Use
Compassionate Use Policy - BioMarin
What is a Compassionate Use Program? - WEP Clinical
The EU's compassionate use mechanism for drugs. | Download Table
Compassionate Use Programmes - Paul-Ehrlich-Institut
Compassionate Use and other Managed Access Concepts - GMP Journal
Compassionate Use Programmes - Paul-Ehrlich-Institut
Regeneron Compassionate Use Policy
European Medicines Agency Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands Subject: IV Zanamivir Procedure No. EMA/H
PDF) Compassionate use programs in Italy: Ethical guidelines
Manufacturer's Compassionate Use Policies: Companies with Posted Policies More Than Doubled Since September 2016
Compassionate use of drugs and medical devices in the United States, the European Union and Japan - ScienceDirect
The Global Guide to Compassionate Use Programs
Compassionate Use and other Managed Access Concepts - GMP Journal
Compassionate use: Providing access to much needed treatments | Novartis
Compassionate use in Europe
Egetis receives approval in Turkey for compassionate use of Emcitate® for MCT8 deficiency
Compassionate use: Providing access to much needed treatments | Novartis
